Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Irbesartan 300mg / Hydrochlorothiazide 25mg tablets (Bristol Laboratories Ltd) |
| BNF code | 0205052A0AAACAC |
| Virtual Medicinal Product | Irbesartan 300mg / Hydrochlorothiazide 25mg tablets |
| Name | Irbesartan 300mg / Hydrochlorothiazide 25mg tablets |
| Supplier | Bristol Laboratories Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| Irbesartan 300mg / Hydrochlorothiazide 25mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets | |
dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.